GL1X · GenesisL1 explorer

UniProt P0DTC9

Nucleoprotein (P0DTC9)

Nucleoprotein (UniProt P0DTC9): 85 experimental structures on GenesisL1, 18 ligands bound, 136 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P0DTC9
Protein
Nucleoprotein
Experimental structures
85
Predicted models
0
Ligands
18
Pockets
136 · 25 records with a druggable one

Structures

85 records of P0DTC9 in the MolNFT archive: 85 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
6M3MCrystal structure of SARS-CoV-2 nucleocapsid protein N-terminal RNA binding domainx-ray diffractionA, B, C, D—3 (best 0.79)
6M3MCrystal structure of SARS-cov-2 nucleocapsid protein N-terminal RNA binding domainx-ray diffractionA, B, C, D——
6VYOCrystal structure of RNA binding domain of nucleocapsid phosphoprotein from SARS coronavirus 2x-ray diffractionA, B, C, DCL, ZN—
6WJI2.05 ångström resolution crystal structure of C-terminal dimerization domain of nucleocapsid…x-ray diffractionA, B, C, D, E, FCL—
6WKPCrystal structure of RNA-binding domain of nucleocapsid phosphoprotein from SARS cov-2, monoclinic…x-ray diffractionA, B, C, DZN—
6WZOStructure of SARS-CoV-2 Nucleocapsid dimerization domain, P1 formx-ray diffractionA, B, C, D—5 (best 0.46)
6WZOStructure of SARS-cov-2 nucleocapsid dimerization domain, P1 formx-ray diffractionA, B, C, D——
6WZQStructure of SARS-CoV-2 Nucleocapsid dimerization domain, P21 formx-ray diffractionA, B, C, DSO43 (best 0.72)
6WZQStructure of SARS-cov-2 nucleocapsid dimerization domain, P21 formx-ray diffractionA, B, C, DSO4—
6YI3The N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoproteinsolution nmrA—1 (best 0.27)
6YI3The N-terminal RNA-binding domain of the SARS-cov-2 nucleocapsid phosphoproteinsolution nmrA——
6YUN1.45 ångström resolution crystal structure of C-terminal dimerization domain of nucleocapsid…x-ray diffractionA, B——
6ZCOCrystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2…x-ray diffractionA—1 (best 0.62)
6ZCOCrystal structure of C-terminal dimerization domain of nucleocapsid phosphoprotein from SARS-cov-2…x-ray diffractionA——
7ACSThe SARS-cov-2 nucleocapsid phosphoprotein N-terminal domain in complex with 7MER dsrnasolution nmrA——
7ACTThe SARS-cov-2 nucleocapsid phosphoprotein N-terminal domain in complex with 10MER ssrnasolution nmrA——
7C22Crystal structure of the C-terminal domain of SARS-CoV-2 nucleocapsid proteinx-ray diffractionA, B, C, D—6 (best 0.53)
7C22Crystal structure of the C-terminal domain of SARS-cov-2 nucleocapsid proteinx-ray diffractionA, B, C, D——
7CDZCrystal structure of 2019-nCoV nucleocapsid N-terminal domain (NTD) proteinx-ray diffractionA, B, C, D—7 (best 0.85)
7CDZCrystal structure of 2019-ncov nucleocapsid N-terminal domain (ntd) proteinx-ray diffractionA, B, C, D——
7CE0Crystal structure of 2019-ncov nucleocapsid C-terminal domain (ctd) proteinx-ray diffractionA, B, C, D——
7CR5Complex structure of a human monoclonal antibody with SARS-CoV-2 nucleocapsid protein NTDx-ray diffractionAZN1 (best 0.52)
7CR5Complex structure of a human monoclonal antibody with SARS-cov-2 nucleocapsid protein ntdx-ray diffractionAZN—
7DE1Crystal structure of SARS-CoV-2 nucleocapsid protein C-terminal RNA binding domainx-ray diffractionA, B——
7DE1Crystal structure of SARS-cov-2 nucleocapsid protein C-terminal RNA binding domainx-ray diffractionA, B——
7F2BCrystal structure of SARS-cov-2 nucleocapsid protein C-terminal RNA binding domain at 2.0A…x-ray diffractionB, APO4, CL—
7F2ESARS-CoV-2 nucleocapsid protein C-terminal domain (dodecamer)x-ray diffractionB, A, C, D, E, F, G, H, I, J, K, LPO412 (best 0.75)
7F2ESARS-cov-2 nucleocapsid protein C-terminal domain (dodecamer)x-ray diffractionB, A, C, D, E, F, G, H, I, J, K, LPO4—
7KGOCrystal Structure of HLA-A*0201in complex with SARS-CoV-2 N351-359x-ray diffractionC——
7KGOCrystal structure of HLA-A*0201IN complex with SARS-cov-2 N351-359x-ray diffractionC——
7KGPCrystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N316-324x-ray diffractionC——
7KGPCrystal structure of HLA-A*0201 in complex with SARS-cov-2 N316-324x-ray diffractionC——
7KGQCrystal Structure of HLA-A*0201in complex with SARS-CoV-2 N222-230x-ray diffractionC——
7KGQCrystal structure of HLA-A*0201IN complex with SARS-cov-2 N222-230x-ray diffractionC——
7KGRCrystal structure of HLA-A*0201IN complex with SARS-cov-2 N159-167x-ray diffractionC——
7KGSCrystal structure of HLA-A*0201 in complex with SARS-cov-2 N138-146x-ray diffractionC——
7KGTCrystal Structure of HLA-A*0201 in complex with SARS-CoV-2 N226-234x-ray diffractionC—1 (best 0.38)
7KGTCrystal structure of HLA-A*0201 in complex with SARS-cov-2 N226-234x-ray diffractionC——
7LGDHLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113x-ray diffractionE, F——
7LGDHLA-B*07:02 in complex with SARS-cov-2 nucleocapsid peptide N105-113x-ray diffractionE, F——
7LUXAalall segment from the nucleoprotein of SARS-cov-2, residues 217-222, crystal form 2x-ray diffractionA——
7LUZGqtvtk segment from the nucleoprotein of SARS-cov-2, residues 243-248x-ray diffractionA——
7LV2Gsqass segment from the nucleoprotein of SARS-cov-2, residues 179-184x-ray diffractionA——
7N0IStructure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2x-ray diffractionA, B, C, D, E, F, H, GMG12 (best 0.82)
7N0IStructure of the SARS-cov-2 N protein C-terminal domain bound to single-domain antibody E2x-ray diffractionA, B, C, D, E, F, H, GMG—
7N0RStructure of the SARS-cov-2 N protein RNA-binding domain bound to single-domain antibody C2x-ray diffractionA, BSO4—
7N3CCrystal Structure of Human Fab S24-202 in the complex with the N-terminal Domain of Nucleocapsid…x-ray diffractionCIOD, PO42 (best 0.58)
7N3CCrystal structure of human Fab S24-202 in the complex with the N- terminal domain of nucleocapsid…x-ray diffractionCIOD, PO4—
7N3DCrystal Structure of Human Fab S24-1564 in the complex with the N-terminal Domain of Nucleocapsid…x-ray diffractionCCL1 (best 0.44)
7N3DCrystal structure of human Fab S24-1564 in the complex with the N- terminal domain of nucleocapsid…x-ray diffractionCCL—
7O05Crystal structure of SARS-cov-2 N-ctdx-ray diffractionA, B, C, D——
7O35Crystal Structure of SARS-CoV-2 N-CTD in complex with GTP (I)x-ray diffractionA, B, C, DGTP—
7O35Crystal structure of SARS-cov-2 N-ctd in complex with GTP (I)x-ray diffractionA, B, C, DGTP—
7O36Crystal structure of SARS-cov-2 N-ctd in complex with GTP (II)x-ray diffractionA, B, C, DGTP—
7R98Structure of the SARS-cov-2 N protein RNA-binding domain bound to single-domain antibody B6x-ray diffractionA, B, C——
7SD4SARS-CoV-2 Nucleocapsid N-terminal domain (N-NTD) proteinsolid-state nmrA——
7SD4SARS-cov-2 nucleocapsid N-terminal domain (N-ntd) proteinsolid-state nmrA——
7STRCrystal structure of human Fab S24-1063 in the complex with the N- teminal domain of nucleocapsid…x-ray diffractionC——
7STSCrystal Structure of Human Fab S24-1379 in the Complex with the N-teminal Domain of Nucleocapsid…x-ray diffractionC, D—4 (best 0.80)
7STSCrystal structure of human Fab S24-1379 in the complex with the N- teminal domain of nucleocapsid…x-ray diffractionC, D——

25 records more on the page itself.

Ligands

  • CL · Chloride ion · in 8 records
  • SO4 · Sulfate ion · in 6 records
  • PO4 · Phosphate ion · in 5 records
  • ZN · Zinc ion · in 5 records
  • GTP · Guanosine-5'-triphosphate · in 3 records
  • IOD · Iodide ion · in 2 records
  • MG · Magnesium ion · in 2 records
  • NA · Sodium ion · in 2 records
  • 5GP · Guanosine-5'-monophosphate · in 1 record
  • 657 · 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine · in 1 record
  • A1H88 · 2-amino-1,3-benzothiazol-6-ol · in 1 record
  • CD · Cadmium ion · in 1 record
  • GKP · (2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}butanedioic acid · in 1 record
  • GMP · Guanosine · in 1 record
  • GUN · Guanine · in 1 record
  • K · Potassium ion · in 1 record
  • SCN · Thiocyanate ion · in 1 record
  • U2H · ~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-yl)methyl]propan-1-amine · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.